Monopril and Zerit drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Monopril (fosinopril sodium) and Zerit (stavudine). Common drug interactions include malignant neoplasm of lacrimal duct among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Monopril and Zerit. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Monopril?

Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.

What is Zerit?

Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

17 people who take Monopril and Zerit together, and have interactions are studied.

What are the common drug interactions of Monopril and Zerit, by gender? *:

female:

Malignant neoplasm of lacrimal duct (cancer tumour of tear duct)
Pancreatitis acute (sudden inflammation of pancreas)
Type 2 diabetes mellitus

male:

Dehydration (dryness resulting from the removal of water)
Abdominal pain upper
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Diarrhoea
Dizziness (excl vertigo)
Abdominal tenderness
Blood calcium decreased
Nausea (feeling of having an urge to vomit)
Blood amylase increased
Blood triglycerides increased

What are the common drug interactions of Monopril and Zerit, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Malignant neoplasm of lacrimal duct (cancer tumour of tear duct)
Pancreatitis acute (sudden inflammation of pancreas)
Type 2 diabetes mellitus

30-39:

n/a

40-49:

Dehydration (dryness resulting from the removal of water)
Abdominal pain upper
Cholecystitis (infection of gallbladder)
Depression
Heart rate increased
Urinary tract infection
Blood sodium decreased
Pyrexia (fever)
Vomiting
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)

50-59:

Abdominal pain upper
Necrosis (the death of body tissue)
Peripheral neuropathy (damage to nerves of the peripheral nervous system)
Peripheral vascular disease
Pressure sore
Renal failure acute (rapid kidney dysfunction)
Septic spots (spots due to blood infection)
Staphylococcal infection (an infection with staphylococcus bacteria)
Thrombosis (formation of a blood clot inside a blood vessel)
Urinary tract infection

60+:

Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Stress And Anxiety: 2 people, 11.76%
Post-Traumatic Stress Disorder: 2 people, 11.76%
Insomnia (sleeplessness): 2 people, 11.76%
Hepatitis C: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Monopril and Zerit?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously